Submitted by dcc on Mon, 2021-11-29 10:36 Study Title: A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter GlioblastomaCIRB: Adult CIRB - Late Phase EmphasisLead Group: NRGStatus: ActiveReview Status: Available to Open
